Examining the gap between evidence based guidelines and clinical practice in lipid modification in adults at high risk of cardiovascular disease mortality: evidence from an Irish cohort
Murphy, CatrionaORCID: 0000-0002-3262-1130, Bennett, Kathleen, Shelley, Emer, Graham, Ian, Fahey, Tom and Kenny, Rose Anne
(2014)
Examining the gap between evidence based guidelines and clinical practice in lipid modification in adults at high risk of cardiovascular disease mortality: evidence from an Irish cohort.
In: EuroPRevent, 8-10 May 2014, Amsterdam, Netherlands.
The role of statins in the secondary prevention of
cardiovascular disease (CVD) is well established. Statin
therapy is also recommended as part of the management
strategy for diabetics.
In asymptomatic individuals, statins are recommended if
their Systematic Coronary Risk Estimation (SCORE) of
10 year CVD mortality is high (≥5% and ≤10%) or very
high (≥10%) and Low-Density Lipoprotein (LDL-C) levels
are above defined intervention thresholds.